The estimated Net Worth of Jeffrey Scott Stein is at least $816 Tausend dollars as of 7 August 2024. Mr. Stein owns over 25,000 units of AMBAC stock worth over $373,100 and over the last 12 years he sold AMBC stock worth over $0. In addition, he makes $443,000 as Independent Chairman of the Board at AMBAC.
Sign up
Mr. Stein AMBC stock SEC Form 4 insiders trading
Jeffrey has made over 9 trades of the AMBAC stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 25,000 units of AMBC stock worth $270,500 on 7 August 2024.
The largest trade he's ever made was buying 25,000 units of AMBAC stock on 7 August 2024 worth over $270,500. On average, Jeffrey trades about 1,080 units every 68 days since 2012. As of 7 August 2024 he still owns at least 35,000 units of AMBAC stock.
You can see the complete history of Mr. Stein stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jeffrey Stein biography
Jeffrey S. Stein serves as Independent Chairman of the Board of the Company. Mr. Stein has been Chairman of the Board since January 1, 2015 and has served as a director since May 1, 2013. Mr. Stein is Founder and Managing Partner of Stein Advisors LLC, a financial advisory firm that provides consulting services to public and private companies and institutional investors. Mr. Stein is an investment professional with over twenty-seven years of experience in the high yield, distressed debt and special situations equity asset classes who has substantial experience investing in the financial services industry. Previously Mr. Stein was a Co-Founder and Principal of Durham Asset Management LLC, a global event-driven distressed debt and special situations equity asset management firm. From January 2003 through December 2009 Mr. Stein served as the Co-Director of Research at Durham responsible for the identification, evaluation and management of investments for the various Durham portfolios. From July 1997 to December 2002 Mr. Stein served as Co-Director of Research at The Delaware Bay Company, Inc., a boutique research and investment banking firm focused on the distressed debt and special situations equity asset classes. From September 1991 to August 1995, Mr. Stein was an Associate/Assistant Vice President at Shearson Lehman Brothers in the Capital Preservation & Restructuring Group. Mr. Stein currently serves as a board observer on the Board of TORM plc. Mr. Stein previously served as a director on the Boards of Dynegy Inc. and Westmoreland Coal Company. Mr. Stein received a B.A. in Economics from Brandeis University and an M.B.A. with Honors in Finance and Accounting from New York University.
What is the salary of Jeffrey Stein?
As the Independent Chairman of the Board of AMBAC, the total compensation of Jeffrey Stein at AMBAC is $443,000. There are 11 executives at AMBAC getting paid more, with Claude LeBlanc having the highest compensation of $5,588,240.
How old is Jeffrey Stein?
Jeffrey Stein is 50, he's been the Independent Chairman of the Board of AMBAC since 2015. There are 11 older and 6 younger executives at AMBAC. The oldest executive at AMBAC Financial Group Inc. is Claude Prieur, 69, who is the Independent Director.
What's Jeffrey Stein's mailing address?
Jeffrey's mailing address filed with the SEC is AMBAC FINANCIAL GROUP, INC., ONE WORLD TRADE CENTER, 41ST FLOOR, NEW YORK, NY, 10007.
Insiders trading at AMBAC
Over the last 2001 years, insiders at AMBAC have traded over $0 worth of AMBAC stock and bought 620,503 units worth $8,494,882 . The most active insiders traders include Claude Le Blanc, Tavakoli Nader und C James Prieur. On average, AMBAC executives and independent directors trade stock every 3430 days with the average trade being worth of $117,111. The most recent stock trade was executed by R Sharon Smith on 8 August 2024, trading 1,100 units of AMBC stock currently worth $11,704.
What does AMBAC do?
ambac financial group, inc. (“ambac”), headquartered in new york city, is a holding company whose subsidiaries, including its principal operating subsidiary, ambac assurance corporation (“ambac assurance”), everspan financial guarantee corporation, and ambac assurance uk limited, provided financial guarantees and other financial services to clients in both the public and private sectors globally. ambac assurance, including the segregated account of ambac assurance (in rehabilitation), is a guarantor of public finance and structured finance obligations. ambac is also exploring opportunities involving the development or acquisition of new financial services businesses. ambac’s common stock trades on the nasdaq global select market (nasdaq: ambc)
What does AMBAC's logo look like?
Complete history of Mr. Stein stock trades at AMBAC
AMBAC executives and stock owners
AMBAC executives and other stock owners filed with the SEC include:
-
Claude LeBlanc,
President, Chief Executive Officer, Director -
Claude L. LeBlanc,
Pres, CEO & Director -
David Trick,
Chief Financial Officer, Executive Vice President, Treasurer -
Stephen Ksenak,
General Counsel, Senior Managing Director -
David Barranco,
Senior Managing Director -
David Trick,
Exec. VP, CFO & Treasurer -
R. Sharon Smith,
Senior Managing Director, Chief of Staff -
Stephen Michael Ksenak,
Sr. MD & Gen. Counsel -
David Peter Barranco,
Sr. MD and Head of Risk Management & Corp. Devel. -
Rhonta Sharon Smith,
Sr. MD & Chief of Staff -
Robert Eisman,
Chief Accounting Officer, Senior Managing Director, Controller -
Jeffrey Stein,
Independent Chairman of the Board -
David Herzog,
Independent Director -
Alexander Greene,
Independent Director -
Ian Haft,
Independent Director -
Claude Prieur,
Independent Director -
Joan Lamm-Tennant,
Independent Director -
Lisa Kampf,
Managing Director -
Michael Reilly,
Chief Administrative Officer, Chief Information Officer, Senior Managing Director -
Kate Smith,
Director of Corp. Communications -
Charles Joseph Sebaski,
MD & Head of Investor Relation -
Daniel Matthew McGinnis,
Sr. MD & COO -
Dan McGinnis,
Sr. MD & COO -
Patrick McCormick,
Managing Director -
Robert Bryan Eisman,
Sr. MD, Chief Accounting Officer & Controller -
Robert G. Donovan,
Chief Investment Officer -
Tavakoli Nader,
Director -
C James Prieur,
Director -
Cathleen Matanle,
Senior Managing Director -
Eugene M Bullis,
Director -
Victor E Mandel,
Director -
Diana Adams,
Chief Executive Officer -
Lisa G Iglesias,
Director -
Michael D Price,
Director -
Kristi Ann Matus,
Director -
Daniel Mc Ginnis,
Sr. MD & COO